In the course of past litigation pending in the U.S. District Court for the District of Nevada between Relmada Therapeutics, Inc. and Laidlaw & Company, Ltd and its principals, Matthew Either and James Ahern, the court “enjoined Laidlaw from continuing to disseminate false and misleading proxy materials.” Laidlaw, which had previously been Remalda’s investment banker, was seeking to gain control of Relmada. Laidlaw had a history of violating U.S. financial regulations. In its order the court stated that the injunction was necessary to prevent Relmada and its stockholders from irreparable harm.”
Either and Ahern have continued to run afoul of U.S. financial regulations. Laidlaw & Company is a investment bank located in the U.K. which has gained a reputation for dubious ethics. People who interned at Laidlaw uniformly described it as a bad place to work.
A Laidlaw broker, Leonard V. Gallick, Jr., has been the subject of numerous complaints which has led the securities and investment fraud law firm of Fitapelli to solicit additional complaints regarding this Laidlaw broker.
While it is difficult to determine the exact character of Laidlaw and its principals, Matthew Either and James Ahern, based on the limited available information regarding them it appears that Laidlaw may be a notorious investment bank with unscrupulous financial practices. My advice would be to avoid doing business with them, but, if it’s cutthroat you want, then Laidlaw may be just the right choice.